QuantuMDx - Changing healthcare, Globally

QuantuMDx Group Logo
Tackling humanitarian
health priorities
Malaria, TB & HIV diagnosis and drug resistance status for a few dollars
The Handheld Laboratory
15 minute disease diagnosis at the
touch of a button
Personalising Medicine
Right first time prescribing for your patients
Digitizing Biology
Translating DNA the code of life into binary code
One Device,
Endless Possibilities
Flexibility to extract and analyse DNA from most sample types
Our Commercial testing laboratory
One Device, Endless Possibilities™
Q-POC™: The Handheld Laboratory

Q-POC™: The Handheld Laboratory.
QuantuMDx is The Future.
Our handheld laboratory will deliver complex diagnostics in minutes for a few dollars in any setting across the globe.

Device Overview

Q-POC™: The Handheld Laboratory

Our pioneering handheld DNA analyzer
will provide an accurate molecular diagnostic result in 10-15 minutes.

Our Devices

Q-POC™ will provide the accuracy, sensitivity and specificity of a state of the art referral laboratory, at the patient's side and at a fraction of the cost. Much like the success of the smartphone/app model, Q-POC™ will thrive thanks to the ability to run numerous different tests using a single device.

To run a sample-to-result molecular diagnostic test, simply

  1. Insert a sample into the disease-specific cartridge
  2. Insert a the cartridge into Q-POC™ the universal handheld reader
  3. Press the "Go" button on the touchscreen
  4. Results and drug resistance information displayed in 10-15 minutes

The power of DNA analysis in the pocket of your lab coat

  • Rapid: Rapid response diagnostics and drug resistance analysis with results in
    10-15 minutes, enabling immediate treatment and containment of infections
  • Affordable: A handheld lab for the price of a smartphone, with each test costing just
    $5-20 depending on the complexity of the test
  • Robust: Designed for use in remote or resource scarce settings, with no need for a stable electricity source or clean water
  • Mobile: DNA analysis in any setting across the globe, from a remote village in Gabon,
    a busy hospital in Mumbai or a city hospital in the USA
  • User-friendly: Intuitive touchscreen display, single button operation and all reagents
    on-board the disposable test cartridge
  • Adaptable: The results you need, from a yes/no answer to a full DNA analysis pathology report
  • Connected: Store and share information with a secure mobile data connection, and track the spread emerging infections in real time with global positioning technology

Meet us at 2015 BIO International Convention, Philadelphia

COO Dr Sam Whitehouse and Business Development Manager Dr Jonathan Peat will be attending, based at UKTI’s UK Pavilion, and are looking forward to meeting people to discuss Q-POC and the company’s latest DNA extraction technology Q-Prep. To arrange a meeting contact Dr Jonathan Peat on jonathan.peat@quantumdx.com.

CSO Jonathan O’Halloran chaired the Point of Care Diagnostics Symposia at Molecular Medicine Tricon in San Francisco...

and was back in the UK for a half marathon the following day!

Business Development Executive Maggie Love is looking forward to the Africa Healthcare Summit

including meetings with Ministries of Health.

CEO Elaine Warburton will speak at the Royal Society of Medicine’s Recent Developments in Digital Health

this week, giving attendees a glimpse of the future of diagnostics.

QuantuMDx invited to Wellcome Trust’s Review of Antimicrobial Resistance

Jonathan O’Halloran has been invited to sit on a diagnostics panel at the Wellcome Trust’s first event of the Review of Antimicrobial Resistance, an event tackling a crisis for the health and wealth of nations.
Read more >

QuantuMDx attended JP Morgan Healthcare Conference in San Francisco

If you would like to meet, please email Maggie Love - info@quantumdx.com

FIND and QuantuMDx partnering to developing breakthrough technology for tuberculosis detection and drug resistance determination

FIND, a Geneva-based non-profit organization and QuantuMDx Group, a British medical device developer are joining forces in developing a paradigm changing solution for the combined detection of and drug susceptibility determination for the causative agent for tuberculosis. Based on the molecular detection of an extensive set of genetic markers by the simple handheld Q-POC™ device developed by QuantuMDx, the time for full antimycobacterial resistance profiling will be reduced from weeklong to less than half an hour.
Read more >

QuantuMDx announce prototype handheld lab for 15 minute DNA-based diagnosis

At the TEDMED 2014 conference, medical device developers QuantuMDx Group announced the successful production of their first fully-integrated sample-to-result working prototype of Q-POC™, a handheld lab that delivers your DNA-based medical diagnosis in minutes. The Group believes the future of disease management and drug resistance monitoring is networked geo-stamped data, a functionality provided by the handheld Q-POC™ device. Rapid and low cost testing will enable continuous monitoring of disease and antimicrobial resistance throughout populations, as well as surveillance for emerging novel pathogen threats such as Ebola.
Read more >

QuantuMDx DevicesQuantuMDx DevicesQuantuMDx Mission StatementQuanutMDx ProductsQuantuMDx Devices